Enovis (ENOV) Change in Receivables (2010 - 2026)
Enovis' (ENOV) quarterly Change in Receivables came in at $4.3 million in Q2 2026, down 72.79% year-on-year from $16.0 million in Q2 2025, and down 59.51% on a QoQ basis from $10.7 million in Q4 2025.
Enovis (ENOV) Change in Receivables (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Change in Receivables data on file, last reported at $4.3 million in Q2 2026.
- On a quarterly basis, Change in Receivables fell 72.79% year-over-year to $4.3 million in Q2 2026; TTM through Apr 2026 was -$878000.0, a 101.44% decrease from a year earlier, with the FY2025 full-year figure at $10.8 million, down 81.15% from the prior year.
- Change in Receivables for Q2 2026 stood at $4.3 million, down from $10.7 million in the prior quarter.
- Over the last five years, Change in Receivables for ENOV reached as high as $27.9 million in Q4 2024 and fell as low as -$20.8 million in Q4 2025.
- Historically, Change in Receivables has averaged $7.9 million across 5 years, with a median of $10.7 million in 2025.
- Across the five-year window, Change in Receivables jumped 422.36% in 2023 and tumbled 575.05% in 2025, its largest moves.
- Year by year, Change in Receivables stood at $1.9 million in 2022, then soared by 422.36% to $9.8 million in 2023, then soared by 184.65% to $27.9 million in 2024, then tumbled by 61.47% to $10.7 million in 2025, then sank by 59.51% to $4.3 million in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were $4.3 million in Q2 2026, $10.7 million in Q4 2025, and -$20.8 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | 4.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 4.35 Mn |
| Apr 3, 2026 | 4.35 Mn |
| Dec 31, 2025 | 10.74 Mn |
| Dec 31, 2025 | 10.74 Mn |
| Oct 3, 2025 | -20.81 Mn |
| Oct 3, 2025 | -20.81 Mn |
| Jul 4, 2025 | 4.85 Mn |
| Jul 4, 2025 | 4.85 Mn |
| Apr 4, 2025 | 15.98 Mn |
| Apr 4, 2025 | 15.98 Mn |
| Dec 31, 2024 | 27.86 Mn |
| Dec 31, 2024 | 27.86 Mn |
| Sep 27, 2024 | 4.38 Mn |
| Sep 27, 2024 | 4.38 Mn |
| Jun 28, 2024 | 12.80 Mn |
| Jun 28, 2024 | 12.80 Mn |
| Mar 29, 2024 | 12.01 Mn |
| Mar 29, 2024 | 12.01 Mn |
| Dec 31, 2023 | 9.79 Mn |
| Dec 31, 2023 | 9.79 Mn |